Nutrition as a Determinant of Labor Outcome

NCT ID: NCT00367549

Last Updated: 2011-07-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-09-30

Study Completion Date

2009-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a randomized, double-blind trial looking at how nutrition intake is associated with labor progress and complications.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Insufficient intake of energy during labor may result in poor labor progress. The study investigates the effect of an energy supplement during labor.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Labor, Obstetric

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Energy-containing soft drink

Commercial energy/sports drink

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women at gestational age \> 36 weeks, parity 0

Exclusion Criteria

* Gestational age \< 36 weeks
* Signs of fetal pathology:

* Different or abnormal (pathological) CTG test performed just before start of the test
* Abnormal Doppler registrations (PI in the arteria umbilicae \> 2SD for the gestational age)
* Established notch in the arteria uterinae or notch bilaterally or PI \> 2SD \> 24 weeks
* Diverging in the weight of the fetus \> - 22% or diverging in the growth of the fetus - 10% or more, and established structural pathology in the fetus, oligohydramnion (amniotic fluid index \< 6)
* Maternal diseases and pregnancy complications

* diabetes in pregnancy
* high blood pressure
* cardiovascular diseases
* rheumatic disease
* epilepsia
* lung disease, etc.

CTG test: cardiotocographic test (a measure of fetal activity)

PI: pulsatory index (velocity pattern)

SD: standard deviation
Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Oslo

OTHER

Sponsor Role collaborator

Oslo University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rikshospitalet University Hospital

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tore Henriksen, MD

Role: PRINCIPAL_INVESTIGATOR

Oslo University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kristin Kardel

Oslo, , Norway

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Norway

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REK-SØR: S-05308

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Calcium Carbonate on Labor Induction
NCT06352775 ACTIVE_NOT_RECRUITING NA
Effectiveness of Evening Primrose Oil for Induction of Labor
NCT06539975 NOT_YET_RECRUITING EARLY_PHASE1
Anticholinergics for Cervical Edema in Labor
NCT06702670 NOT_YET_RECRUITING PHASE2/PHASE3
Birth Environment of the Future
NCT02478385 COMPLETED NA